ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 119 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $135,377 | -68.4% | 20,266 | -62.6% | 0.00% | – |
| Q2 2023 | $428,638 | +90713.1% | 54,258 | +9.2% | 0.00% | – |
| Q1 2023 | $472 | +333.0% | 49,707 | +216.6% | 0.00% | – |
| Q4 2022 | $109 | -99.8% | 15,700 | +42.7% | 0.00% | – |
| Q3 2022 | $58,000 | +41.5% | 11,000 | +6.7% | 0.00% | – |
| Q2 2022 | $41,000 | -54.4% | 10,309 | -48.2% | 0.00% | – |
| Q1 2022 | $90,000 | 0.0% | 19,900 | -10.4% | 0.00% | – |
| Q4 2021 | $90,000 | -42.7% | 22,200 | +26.1% | 0.00% | – |
| Q3 2021 | $157,000 | – | 17,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,400,239 | $6,224,000 | 4.02% |
| Tri Locum Partners LP | 1,447,445 | $6,434,000 | 2.51% |
| Knoll Capital Management, LLC | 759,405 | $3,376,000 | 2.12% |
| Perceptive Advisors | 9,903,879 | $44,023,000 | 0.88% |
| JOHNSON & JOHNSON | 394,834 | $1,755,000 | 0.33% |
| APOGEM CAPITAL LLC | 104,042 | $462,000 | 0.32% |
| Ikarian Capital, LLC | 375,000 | $1,667,000 | 0.22% |
| 683 Capital Management, LLC | 500,000 | $2,223,000 | 0.12% |
| Verition Fund Management LLC | 2,105,907 | $9,361,000 | 0.11% |
| Palo Alto Investors LP | 160,800 | $715,000 | 0.06% |